Treatment Options & Access for EBV+ PTLD
New Rare Cancer Treatment on the Horizon
Addressing Unmet Needs in the PH1 Patient Population
Accessing Treatment for Amyloidosis
In Their Own Voices: The Lived Experiences of IgG4-RD Patients – Report Update
The Danger of Prior Authorization for Rare Cancer Patients
2022 Amyloidosis Initiative Meeting Summary
Patient-Centered Care: A Position Statement
Urgent Action Paused by Prior Authorization
There’s no ‘Moonshot’ or ‘Warp Speed’ for rare diseases. There should be
